<DOC>
	<DOCNO>NCT01905709</DOCNO>
	<brief_summary>The objective study provide treatment Fecal Microbiota Transplantation ( FMT ) patient recurrent refractory Clostridium difficile infection ( CDI ) . It show good bacteria ( like find stool healthy donor ) attack Clostridium difficile multiple way : make substance kill Clostridium difficile - attach surface colon lining , prevents Clostridium difficile toxin ( poison ) attaching . FMT involve infuse mixture saline stool healthy donor bowel patient CDI colonoscopy . The method use deliver FMT depend individual characteristic subject discretion treat physician . FMT may administer follow method . - Colonoscopy : This method allow full endoscopic examination colon exclusion comorbid condition ( IBD , malignancy microscopic colitis ) may impact subject 's treatment response therapy . - Sigmoidoscopy : This method still allow infusion stool proximal segment colon enema , may require sedation . This method may beneficial subject elderly multiparous may difficulty retain material give enema . Sigmoidoscopic administration eliminate additional risk associate colonoscopy subject may clear indication colonoscopy . - Retention enema : This method may preferable young subject already recent endoscopic evaluation , subject prefer undergo endoscopy subject significant co morbidity may tolerate endoscopy . The physician administer 300-500 mL fecal suspension aliquot 60 mL , colonoscope sigmoidoscope 150 mL via retention enema . In case colonoscopic delivery , material deliver proximal point insertion . The subject encourage retain stool long possible .</brief_summary>
	<brief_title>Fecal Microbiota Transplantation C Diff Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>1 . Subject least 18 year old . 2 . Subject recurrent relapse CDI define : At least three episode mildtomoderate CDI failure 68 week taper vancomycin without alternative antibiotic ( e.g. , rifaximin , nitazoxanide , fidaxomicin ) . OR At least two episode severe CDI result hospitalization associate significant morbidity . OR Moderate CDI respond standard therapy ( vancomycin ) least week . OR Severe C. difficile infection toxic megacolon , respond standard therapy use IVIg . 3 . Subject willing able provide inform consent . 4 . If female childbearing potential , subject agree use acceptable form birth control 4 week FMT treatment . 1 . Subject pregnant . 2 . Subject unable comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>C diff</keyword>
	<keyword>CDI</keyword>
	<keyword>clostridium difficile associate diarrhea</keyword>
</DOC>